guardant360® cdx receives fda approval
Published 3 years ago • 357 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
0:51
what is guardant360® cdx?
-
0:58
leading oncologist shares his thoughts fda-approved guardant360® cdx liquid biopsy test
-
8:03
fda approved, guardant360 cdx delivers critical genomic info to oncologists from simple blood draw.
-
0:37
what to expect after your guardant360® cdx cgp test
-
1:06
what is guardant360 response™ and how does treatment monitor testing work?
-
1:20:38
9/3 cvvh
-
3:35
epigenomics in precision oncology
-
2:27
dennis' shield™ story: screening for colorectal cancer
-
0:22
guardant360® detects more guideline-recommended biomarkers than tissue testing
-
0:22
85.7 percent had objective tumor response after guardant360® test
-
0:23
guardant360 test’s 7 days turnaround time
-
3:03
colorectal cancer patient case - where the guardant360® test was used
-
2:28
nile study findings using guardant360® liquid biopsy
-
1:14
what is guardant reveal™ & how can it help monitor my cancer treatment?
-
0:54
you've taken your guardant360 response™ test - what's next?
-
0:43
guardant health transforming cancer care at all stages of the disease
-
7:47
guardant health - blood-based screening for colorectal cancer
-
0:50
understand guardant360 response™: is my cancer treatment working?
-
0:41
prof. arkenau speaks about using guardant360® for patients with advanced gastrointestinal cancer.
-
0:37
is colorectal cancer preventable?
-
0:54
guardant reveal™ launch